An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral

Liver Transplantation and Surgery

Volumn 4, Issue 5, 1998, Pages 410-415

  Pasha, T M ^a   Wiesner, R H ^a   Dahlke, L M ^a   Porayko, M K ^a   Krom, R A F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISONE;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 0031681429     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040507     Document Type: Article

References (12)

1. 1 Kahan BD. Cyclosporine. N Engl J Med 1989 ; 321: 1725–1738. MEDLINE
2. 2 Trull AK, Tan KK, Tan L, Alexander GJ, Jamieson NV. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion. Br J Clin Pharmacol 1995 ; 39: 627–631. MEDLINE
3. 3 Girault D, Haloun A, Viard L, Bellon G, Gottrand F, Guillemain R, et al. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter‐individual variations in patients affected with cystic fibrosis. Transplant Proc 1995 ; 27: 2488–2490. MEDLINE
4. 4 Friman S, Backman L. A new microemulsion formulation of cyclosporin: Pharmacokinetic and clinical features. Clin Pharm 1996 ; 30: 181–193.
5. 5 Levy GA. Neoral therapy in liver transplantation. Transplant Proc 1996 ; 28: 2225–2228. MEDLINE
6. 6 Levy GA, Grant D. Neoral in liver transplantation. Transplant Proc 1996 ; 28: 1019–1021. MEDLINE
7. 7 Farges O, Haddad N, Girault D, Cabiac MD, Samuel D, Bismuth H. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in liver transplant patients with cholestasis or external biliary drainage. Transplant Proc 1995 ; 27: 2506–2507. MEDLINE
8. 8 Pollard SG, Lodge JPA. Conversion from Sandimmune to Neoral in stable liver graft recipients. Transplant Proc 1996 ; 28: 2244–2246. MEDLINE
9. 9 Griffin PJ, Moore RH, Jurewicz WA, Lord RH, Webley Y, Jenkins J. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population. Transplant Proc 1997 ; 29: 303. MEDLINE
10. 10 Donovan JP, Sorrell MF, Langas AN, Donovan CA, Schafer DF. A comparison of two cyclosporine preparations in long‐term liver transplant recipients [abstract]. Hepatology 1997 ; 26: 237.
11. 11 Laine J, Hopper K, Jalauko H, Ronnholm K, Holmberg C. Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allograft. Transplantation 1997 ; 63: 1768–1772. MEDLINE
12. 12 Neumayer HH, Farber L, Haller P, Kohnen R, Maibucher A, Schuster A, et al. Conversion from Sandimmune to Sandimmune Neoral in patients with stable renal allografts: Results after 1 month. Transplant Proc 1994 ; 26: 2944–2948. MEDLINE